ORIC Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEXTECH INVEST, LTD. | 05/15/2026 | 7.16 M | $90.75 M | 0.00% | 8.16% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 6.73 M | $85.25 M | 0.00% | 7.66% |
| BLACKROCK, INC. | 05/13/2026 | 5.98 M | $75.82 M | 1.86% | 6.82% |
| VIKING GLOBAL INVESTORS LP | 05/15/2026 | 5.82 M | $73.80 M | -11.38% | 6.63% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 5.39 M | $68.26 M | 63.51% | 6.14% |
| PFIZER INC | 05/12/2026 | 4.78 M | $57.65 M | -11.08% | 5.45% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/14/2026 | 4.51 M | $58.48 M | 0.00% | 5.14% |
| ALKEON CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.50 M | $57.07 M | 0.00% | 5.13% |
| VR ADVISER, LLC | 05/15/2026 | 4.32 M | $54.73 M | -23.90% | 4.92% |
| NEA MANAGEMENT COMPANY, LLC | 05/15/2026 | 4.12 M | $52.18 M | 0.00% | 4.69% |
| STATE STREET CORP | 05/15/2026 | 3.70 M | $46.91 M | -13.06% | 4.22% |
| 05/15/2026 | 3.69 M | $46.71 M | 100.00% | 4.20% | |
| COLUMN GROUP LLC | 05/18/2026 | 3.54 M | $44.86 M | 0.00% | 4.03% |
| SIREN, L.L.C. | 05/14/2026 | 3.00 M | $37.99 M | 197.57% | 3.42% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 2.69 M | $34.13 M | -26.03% | 3.07% |
| 05/08/2026 | 2.46 M | $31.16 M | 100.00% | 2.80% | |
| FMR LLC | 05/15/2026 | 2.43 M | $30.84 M | -1.81% | 2.77% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.42 M | $30.70 M | -0.49% | 2.76% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 2.02 M | $25.56 M | 0.35% | 2.30% |
| VIVO CAPITAL, LLC | 05/20/2026 | 1.85 M | $23.42 M | -12.73% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.84 M | $23.30 M | 5.03% | 2.09% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.80 M | $22.86 M | 0.29% | 2.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 1.70 M | $21.55 M | -29.15% | 1.94% |
| MORGAN STANLEY | 05/15/2026 | 1.68 M | $21.32 M | 40.91% | 1.92% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.48 M | $18.70 M | -23.90% | 1.68% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.47 M | $18.64 M | 19.89% | 1.68% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.45 M | $18.41 M | 19.82% | 1.65% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 1.40 M | $17.74 M | 16.67% | 1.59% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.25 M | $15.81 M | 406.02% | 1.42% |
| ROYCE & ASSOCIATES LP | 05/12/2026 | 1.21 M | $15.30 M | -19.91% | 1.38% |
| BRAIDWELL LP | 05/15/2026 | 1.13 M | $14.29 M | 100.00% | 1.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.10 M | $13.94 M | -1.49% | 1.25% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.04 M | $13.22 M | 105.54% | 1.19% |
| EUCLIDEAN CAPITAL LLC | 05/15/2026 | 989.41 K | $12.54 M | 0.00% | 1.13% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 960.52 K | $12.17 M | -9.71% | 1.09% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 953.45 K | $12.08 M | 0.11% | 1.09% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 950.00 K | $12.04 M | 111.11% | 1.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 859.49 K | $10.89 M | -28.70% | 0.98% |
| 06/12/2026 | 842.93 K | $10.68 M | 100.00% | 0.96% | |
| NORTHERN TRUST CORP | 05/14/2026 | 710.86 K | $9.01 M | -19.72% | 0.81% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 679.58 K | $8.61 M | 100.00% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 605.04 K | $7.67 M | -2.58% | 0.69% |
| CANDRIAM S.C.A. | 04/30/2026 | 574.09 K | $7.27 M | 100.00% | 0.65% |
| 05/08/2026 | 570.69 K | $7.23 M | 100.00% | 0.65% | |
| LORD, ABBETT & CO. LLC | 05/14/2026 | 542.60 K | $6.88 M | -3.84% | 0.62% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 539.38 K | $6.83 M | 7.37% | 0.61% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 537.63 K | $6.81 M | -46.47% | 0.61% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 523.79 K | $6.64 M | -44.88% | 0.60% |
| 05/14/2026 | 523.62 K | $6.63 M | -14.96% | 0.60% | |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 522.06 K | $6.61 M | 48.78% | 0.59% |
ORIC Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 211 institutional investors and hedge funds held shares of ORIC Pharmaceuticals Inc. The most heavily invested institutionals were:
Nextech Invest, Ltd.: 7.16 M
EcoR1 Capital, LLC: 6.73 M
BlackRock, Inc.: 5.98 M
VIKING GLOBAL INVESTORS LP: 5.82 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.39 M
PFIZER INC: 4.78 M
135.95% of ORIC Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 134.16 M shares in the last 24 months. This purchase volume represents approximately $1.56 B in transactions.